PA317 containing JR-gal
PA317 containing JR-gal
规格:
货期:
编号:TS211155
品牌:Testobio
| 产品名称： | PA317 containing JR-gal |
|---|---|
| 商品货号： | TS211155 |
| Organism： | Mus musculus, mouse |
| Tissue： | embryo |
| Cell Type： | fibroblast |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Age： | embryo |
| Strain： | NIH/Swiss |
| Applications： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Comments： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Subcultivation Ratio: A subcultivation ratio of 1:10 to 1:20 is recommended Medium Renewal: 2 to 3 times per week Remove medium, rinse flask with fresh 0.25% trypsin, 0.02% EDTA and allow the flask to sit at room temperature (or 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks. |
| Name of Depositor： | Wisconsin Alumni Res. Fndn. |
| Deposited As： | Mus musculus |
| U.S. Patent Number： | |
| References： | Gould MN, Wang B. Method for producing a recombinant mammal in vivo. US Patent 5,215,904 dated Jun 1 1993 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
PA317 containing JR-gal
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | PA317 containing JR-gal |
|---|---|
| 商品货号： | TS211155 |
| Organism： | Mus musculus, mouse |
| Tissue： | embryo |
| Cell Type： | fibroblast |
| Product Format： | frozen |
| Morphology： | fibroblast |
| Culture Properties： | adherent |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Age： | embryo |
| Strain： | NIH/Swiss |
| Applications： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Comments： | This cell line was derived from PA317 (see ATCC CRL-9098) by introduction of a retrovirus vector (JR-gal). The vector is derived from the JR vector by incorporation of the E. coli beta galactosidase gene (PstI to SalI fragment of pBAG gag - beta gal fusion protein) into the BamH1 site of JR. |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Subcultivation Ratio: A subcultivation ratio of 1:10 to 1:20 is recommended Medium Renewal: 2 to 3 times per week Remove medium, rinse flask with fresh 0.25% trypsin, 0.02% EDTA and allow the flask to sit at room temperature (or 37C) until the cells detach. Add fresh medium, aspirate and dispense into new flasks. |
| Name of Depositor： | Wisconsin Alumni Res. Fndn. |
| Deposited As： | Mus musculus |
| U.S. Patent Number： | |
| References： | Gould MN, Wang B. Method for producing a recombinant mammal in vivo. US Patent 5,215,904 dated Jun 1 1993 |
